用于口服药物输送的聚合物微粒:临床前研究的进展和创新
Hanan Al-Lawati1, Ziyad Binkhathlan2
1Oman College of Health Sciences, Pharmacy Program, P.O. Box 3720, Ruwi 112, Oman.
International journal of pharmaceutics
|November 12, 2025
概括
聚合物微粒为难溶性药物提供一种新的口服药物输送溶液,增强生物利用性和稳定性. 克服制造和监管障碍是临床成功的关键.
科学领域:
- 聚合物科学和纳米技术
- 制药科学 制药科学
- 药物输送系统 药物输送系统
背景情况:
- 口服药物输送是首选的,但由于许多药物的溶解性差和胃肠道不稳定性而受到挑战.
- 疏水性药物往往由于消化道的吸收和降解不佳,具有较低的生物利用性.
- 需要先进的药物输送系统来克服这些局限性并改善治疗结果.
研究的目的:
- 探索聚合物微粒作为先进的口服药物递送系统的潜力.
- 评估聚合物微粒提高疏水药物的可溶性,稳定性和透性的能力.
- 讨论细胞配方临床翻译的挑战和未来方向.
主要方法:
- 两类块共聚物的自我组装成核心外纳米结构 (聚合物微粒).
- 针对药物保护,控制释放和吸收的细胞配方的临床前评估.
- 具有针对性传递和pH敏感释放的功能部分的工程.
主要成果:
- 聚合物微粒显著提高了水溶性较差的药物的溶性,稳定性和透性.
- 临床前研究表明,对酶降解的保护和通过肠道屏障增强吸收.
- 功能化的菌根使得胃肠道中特定部位的药物释放,提高疗效和降低毒性.
结论:
- 聚合物微粒代表了一个有前途的策略,用于口服提供具有挑战性的疏水性药物.
- 临床翻译受到制造,稳定性和监管挑战的阻碍.
- 跨学科的研究对于开发具有临床可行性的小性口服药物递送系统至关重要.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
186
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
186
Bioavailability Enhancement: Drug Permeability Enhancement
179
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
179
Bioavailability Enhancement: Drug Solubility Enhancement
208
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
208
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
485
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
485
Drug Delivery: Overview
708
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
708


